معرفی
Morgan Philbin, PhD, MHS is an Associate Professor of Medicine at UCSF School of Medicine and an ARC Core Faculty member. She holds a PhD and MHS in Public Health from Johns Hopkins Bloomberg School of Public Health and completed postdoctoral training in HIV/AIDS at Columbia University. Her research examines how social policies and clinical practices impact health equity, focusing on HIV/AIDS, substance use, and sexual/gender minority populations.
Dr. Philbin's research interests center on structural determinants of health disparities, particularly:
- Impact of opioid policies on pregnant people and newborns
- Development of decision aids for HIV treatment modalities
- State-level policies affecting substance use outcomes in marginalized youth
- Long-acting antiretroviral therapy implementation barriers
Her publications predominantly explore HIV treatment innovation, substance use policies, and health disparities through mixed-methods approaches. Recent work demonstrates strong focus on long-acting injectable antiretrovirals, opioid policy impacts, and structural determinants of LGBTQ+ health.
Scientific Awards:
- NIH Early Stage Investigator Lecture Award (2021)
- RFS Award in Science (2024)
- NIDA Director's Travel Award (2020)
- APHA Excellence in Abstract Submission (2016)
- NIH Loan Repayment Program (2014-2017)
She leads multiple NIH grants including:
- R01 on opioid policies' impact on maternal/newborn outcomes (Co-PI)
- R34 developing decision aids for HIV treatment options (PI)
- COVID RADx grant on preventive behaviors in minority youth (Co-I)
- Canadian Institutes of Health grants on SGM substance use (Co-I)
Dr. Philbin collaborates with the AIDS Research Consortium (ARC) and multiple NIH-funded research networks across North America.
